Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights

Go back to Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
(NASDAQ: XERS) Delayed: 8.73 -0.07 (0.8%)
Previous Close $8.80    52 Week High
Open $8.90    52 Week Low
Day High $8.97    P/E N/A 
Day Low $8.64    EPS
Volume 1,688,383